Glaucoma
Care Redefined
Advancing excellence in glaucoma surgical care with exceptional efficacy, safety, and precision for superior patient outcomes.
Home
PLU Ophthalmic revolutionizes glaucoma surgery with its
Next-Generation Glaucoma Surgery technology.
Our advanced, minimally invasive solutions deliver exceptional efficacy, a superior safety profile, and unparalleled precision.
Unlike traditional surgeries that are complex and risky, or MIGS with lower effectiveness,
PLU Ophthalmic Next-Generation Glaucoma
Surgery technology provides a seamless, easy-to-use solution for better patient outcomes and simplified patient management.
THE CHALLENGE
Glaucoma is the second leading cause of blindness worldwide, imposing significant economic costs, especially in the United States.
PREVALENCE:
3 Million
People in the US
80 Million
People globally
IMPACT:
22 Million
People worldwide are at risk of irreversible blindness due to open angle glaucoma.
28 %
Growth rate per decade
ECONOMIC COST:
$2.8 Billion
Direct cost to the US annually (2022)
$12 Billion
Projected cost by 2032 and $17.3 billion by 2050
INDIRECT COSTS:
$44,037
Productivity losses per year, per affected individual
THE SYMPTOMS
Glaucoma is often called the “silent thief of sight” because it usually has no symptoms until significant vision loss has occurred. However, there are some signs and symptoms to watch for, including:
Tunnel Vision
In the advanced stages of the disease
Severe Eye Pain
Associated with acute angle-closure glaucoma
Nausea and Vomiting
Accompanying severe eye pain
Blurred Vision
Especially during a sudden onset
Halos Around Lights
Seeing rainbow-colored rings around lights
Redness in the Eye
This can be a sign of glaucoma
Headaches
Often in conjunction with eye pain
Not Knowing
Half of the people with glaucoma are not aware that they have it
01 / 03
Current Glaucoma Surgical Treatments
Current surgical options force surgeons to choose between efficacy and safety, with no ideal treatment available.
Traditional Intervention: Trabeculectomy
Trabeculectomy is a highly effective procedure for glaucoma, but it carries significant risks and potential complications
RISKS AND COMPLICATIONS FOR TRADITIONAL TRABECULECTOMY:
- High Complication Rates: There is a high incidence of complications such as infection (endophthalmitis), bleeding, hypotony (abnormally low IOP), cataract formation, and challenges in post-surgical patient management.
- Technical Difficulty: Trabeculectomy is technically demanding and requires significant surgical skill. Variability in technique and patient response can affect outcomes. The procedure typically takes around one hour to perform and necessitates extensive training.
- Scarring: Invasive cuts, cauterization, and sutures increase the risk of postoperative scarring at the filtration site. This can lead to the failure of the bleb, reducing the surgery’s effectiveness and often requiring additional interventions.
Minimally Invasive Glaucoma Surgery (MIGS)
Minimally Invasive Glaucoma Surgery (MIGS) aims to provide a high safety profile; however, it offers less than ideal efficacy. Types of MIGS include stents, microshunts, canaloplasties, and goniotomy.
CURRENT MIGS CHALLENGES:
- Limited Long-Term Efficacy: MIGS procedures often result in less IOP reduction, making them insufficient for patients with advanced glaucoma.
- Significant Learning Curve: These procedures are technically challenging, and their success is highly dependent on the surgeon’s skill and experience.
- High Cost: The high cost includes the expense of the devices themselves and the need for specialized training and equipment.
The Future of Glaucoma Treatment
Our innovative approach eliminates the need for compromise, offering a solution that combines high efficacy with superior safety, setting a new standard in glaucoma care.